LEXINGTON, Ky. (WDKY) — University of Kentucky researchers who are involved in a clinical trial on the use of medical ...
Dementia is the term that most commonly comes to mind when one thinks of Alzheimer's, yet there is one more form of cognitive ...
On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...
If approved, tazbentetol could become the first Alzheimer’s therapy to target synaptic degradation.
The holiday season can be a stressful time for many, but for the nearly 12 million family members and friends serving as unpaid caregivers of people living with Alzheimer’s and dementia, the holidays ...
The combination of a recently approved blood test for detection of Alzheimer’s disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...
The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...
Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious stages of ...
In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.